Sales, T.A.; Marcussi, S.; Da Cunha, E.F.F.; Kuca, K.; Ramalho, T.C.
Can Inhibitors of Snake Venom Phospholipases A2 Lead to New Insights into Anti-Inflammatory Therapy in Humans? A Theoretical Study. Toxins 2017, 9, 341.
https://doi.org/10.3390/toxins9110341
AMA Style
Sales TA, Marcussi S, Da Cunha EFF, Kuca K, Ramalho TC.
Can Inhibitors of Snake Venom Phospholipases A2 Lead to New Insights into Anti-Inflammatory Therapy in Humans? A Theoretical Study. Toxins. 2017; 9(11):341.
https://doi.org/10.3390/toxins9110341
Chicago/Turabian Style
Sales, Thaís A., Silvana Marcussi, Elaine F. F. Da Cunha, Kamil Kuca, and Teodorico C. Ramalho.
2017. "Can Inhibitors of Snake Venom Phospholipases A2 Lead to New Insights into Anti-Inflammatory Therapy in Humans? A Theoretical Study" Toxins 9, no. 11: 341.
https://doi.org/10.3390/toxins9110341
APA Style
Sales, T. A., Marcussi, S., Da Cunha, E. F. F., Kuca, K., & Ramalho, T. C.
(2017). Can Inhibitors of Snake Venom Phospholipases A2 Lead to New Insights into Anti-Inflammatory Therapy in Humans? A Theoretical Study. Toxins, 9(11), 341.
https://doi.org/10.3390/toxins9110341